Table 4a.
CD4 IFN-γ ELISPOT assay results. CD4 responses measured by the CD4 IFN-γ ELISPOT assay were graded based on their strength into either negative (blank), weak (W) of less than 25 ELISPOTs/0.5 million PBMCs or strong (S) of 25 or more ELISPOTs/0.5 million PBMCs.
| CD4 RESPONSES | |||||||||||||
| Subject | ICP27 | ICP22 | ICP0–1 | ICP0–2 | ICP0–3 | ICP4–1 | ICP4–2 | ICP4–3 | ICP4–4 | ICP4–5 | ICP4–6 | VP22 | gD |
| 1 | S | S | W | W | W | W | S | W | |||||
| 2 | W | S | S | S | |||||||||
| 3 | W | S | S | S | S | S | S | ||||||
| 4 | |||||||||||||
| 5 | W | W | S | W | S | ||||||||
| 6 | W | W | S | W | W | W | S | S | |||||
| 7 | S | W | |||||||||||
| 8 | W | S | W | W | W | W | |||||||
| 9 | W | S | W | S | W | S | W | W | |||||
| 10 | W | S | |||||||||||
| 11 | W | W | W | W | S | S | |||||||
| 12 | S | S | W | W | W | W | S | S | S | ||||
| 13 | S | S | S | ||||||||||
| 14 | S | ||||||||||||
| 15 | W | S | W | W | W | S | S | ||||||
| 16 | W | S | W | S | |||||||||
| 17 | S | S | |||||||||||
| 18 | W | S | W | W | S | S | S | W | |||||